MM TAX CLUB_whatsapp

MM TAX CLUB

Accounting & Tax Consultancy Firm

Blogs

U.S.–India Interim Trade Agreement: A New Chapter in Bilateral Economic Relations

The United States and India have taken a major step forward in strengthening their economic partnership by announcing a framework for an Interim Trade Agreement. This framework lays the foundation for a broader and more comprehensive U.S.–India Bilateral Trade Agreement (BTA), signaling renewed commitment to reciprocal, balanced, and mutually beneficial trade between the two democracies. 

The announcement reaffirms the intent expressed by U.S. President Donald J. Trump and Indian Prime Minister Narendra Modi on February 13, 2025, when formal BTA negotiations were launched. The Interim Agreement is being positioned as a historic milestone that will enhance market access, improve supply chain resilience, and deepen strategic economic cooperation.


What Does the Interim Agreement Mean?

At its core, the Interim Agreement focuses on reciprocity, market access, and economic security alignment. Both countries have agreed on tangible steps that deliver real trade outcomes rather than only long-term promises.

???? Key Commitments by India

India has agreed to eliminate or reduce tariffs on:

  • All U.S. industrial goods

  • A wide range of U.S. food and agricultural products, including:

    One of the most notable announcements is India’s intention to purchase $500 billion worth of U.S. goods over the next five years, including:

    • Dried Distillers’ Grains (DDGs)

    • Red sorghum (animal feed)

    • Tree nuts

    • Fresh and processed fruits

    • Soybean oil

    • Wine and spirits

    • India has also committed to addressing long-standing non-tariff barriers, especially in:

    • Medical devices

    • Information and Communication Technology (ICT) products

    • Food and agricultural imports

    • Additionally, India will review and align standards and testing requirements for U.S. exports in identified sectors within six months of the agreement’s entry into force.


       Key Commitments by the United States

      The U.S. will apply a reciprocal tariff rate of 18% on certain Indian-origin goods, including:

    • Textiles and apparel

    • Leather and footwear

    • Plastics and rubber

    • Organic chemicals

    • Home décor and artisanal products

    • Certain machinery

      However, subject to the successful conclusion of the Interim Agreement, the U.S. has agreed to remove reciprocal tariffs on several critical Indian exports, such as:

    • Generic pharmaceuticals

    • Gems and diamonds

    • Aircraft parts

    • India will receive preferential tariff-rate quotas for automotive parts, and negotiated outcomes in pharmaceuticals, subject to findings under the U.S. Section 232 investigation.


       Strengthening Supply Chains & Economic Security

      Both countries have agreed to:

    • Establish rules of origin ensuring that benefits flow primarily to the U.S. and India

    • Cooperate on addressing non-market policies of third countries

    • Enhance coordination on:

      • Export controls

      • Investment screening

      • Supply chain resilience

    • This alignment reflects a shared strategic interest in building secure and diversified global supply chains.

      Digital Trade & Technology Cooperation

      The Interim Agreement also sets the stage for robust digital trade rules under the future BTA. Both sides have committed to:

    • Address discriminatory or burdensome digital trade practices

    • Promote fair, transparent, and mutually beneficial digital trade frameworks

    • In a major forward-looking move, the two countries plan to significantly expand trade in technology products, including:

    • Graphics Processing Units (GPUs)

    • Data center infrastructure

    • Advanced technology components

       India’s $500 Billion Purchase Commitment

      The Road Ahead

      The Interim Agreement is not the end goal but a stepping stone toward a full-fledged Bilateral Trade Agreement. Both countries have agreed to promptly implement the framework and continue negotiations to:

    • Expand market access further

    • Lower tariffs on Indian goods

    • As negotiations progress, the U.S.–India trade relationship is poised to enter a new era—one driven by cooperation, trust, and shared economic interests.

    • Finalize ambitious, balanced, and sustainable trade rules

  • Energy products

  • Aircraft and aircraft parts

  • This commitment underscores India’s long-term engagement with U.S. industries and strengthens bilateral trade flows.

  • Precious metals

  • Technology products

  • Coking coal

  • The U.S. will also remove tariffs on aircraft and aircraft parts previously imposed under national security proclamations related to aluminum, steel, and copper imports.

ED Files Prosecution Complaint in Inter-State Drug Trafficking & Money Laundering Case

The Directorate of Enforcement (ED), Jalandhar Zonal Office, has taken a major step against an inter-state drug trafficking network by filing a Prosecution Complaint on 6 February 2026 before the Hon’ble Special Court under the Prevention of Money Laundering Act (PMLA), 2002 at Mohali.

The case involves Abhishek Kumar, Soul Healthcare (I) Pvt. Ltd., M/s Aster Pharma, and several other related individuals and entities. The investigation is linked to the illegal supply of psychotropic and intoxicant substances, including Tramadol and Alprazolam, across state borders.

How the Case Began

The ED initiated its investigation based on an FIR registered by the Punjab Police under the NDPS Act, 1985, following the recovery of Tramadol-based tablets and drug money in cash from drug peddlers.

Key Findings of ED Investigation

The investigation revealed a well-organized network involving manufacturers, distributors, middlemen, and drug peddlers:

  • Middlemen firms such as M/s Shri Shyam Medical Agency, M/s MP Traders, and M/s Kanix Pharma procured large quantities of psychotropic tablets from pharmaceutical manufacturers.

  • These drugs were diverted for illegal cash sales without proper bills, prescriptions, or stock registers.

  • Soul Healthcare (I) Pvt. Ltd., the manufacturer of Tramadol-based tablets, along with its distributor M/s Aster Pharma, was found to be directly involved in illegal sales.

  • Tablets were transported via courier services from manufacturing units to middlemen, who further supplied them to drug peddlers.

  • While invoice-equivalent amounts were routed through bank accounts, excess proceeds were paid in cash, forming the proceeds of crime.

  • Searches, Arrests, and Attachments

  • Searches were conducted on 17 June 2025 under Section 17 of PMLA, resulting in the seizure of ₹4 lakh in cash and incriminating documents.

  • Abhishek Kumar of M/s Shri Shyam Medical Agency was arrested on 9 December 2025 and is currently in judicial custody.

  • Assets worth ₹2.19 crore, including movable and immovable properties belonging to individuals connected with Aster Pharma, Soul Healthcare, Kanix Pharma, MP Traders, and others, were provisionally attached vide Provisional Attachment Order No. 1/2026 dated 02.02.2026.

    A Serious Threat to Society

    The ED has highlighted that this network spans across manufacturers, distributors, and retailers, facilitating the illegal circulation of psychotropic drugs. Such activities pose a serious risk to public health, contributing to widespread misuse and addiction, especially among youth.

    What Lies Ahead

    The filing of the prosecution complaint marks a significant milestone, but further investigation is still underway. The case underscores the government’s continued focus on curbing drug trafficking and dismantling financial networks that fuel such crimes.

ED Files Money Laundering Case Against Ex-Principal of RG Kar Medical College

The Directorate of Enforcement (ED), Kolkata Zonal Office has filed a Prosecution Complaint before the Ld. Chief Judge (PMLA), Kolkata in a money laundering case under the provisions of the Prevention of Money Laundering Act (PMLA), 2002. The case has been filed against Sandip Ghosh, former Principal of RG Kar Medical College and Hospital, along with three other accused entities.

Background of the Case 

 

The ED initiated its investigation based on an FIR dated 24 August 2024 registered by the CBI, ACB Kolkata against Sandip Ghosh and other associated contractors. Subsequently, a chargesheet dated 29 November 2024 was filed under various sections of the Indian Penal Code, 1860 and the Prevention of Corruption Act, 1988.

According to the investigation, Sandip Ghosh allegedly abused his official position to dishonestly and fraudulently extend undue benefits to certain firms. These firms were allegedly operating as a cartel, controlled by co-accused Biplab Singha and Suman Hazra

Modus Operandi Revealed

The ED’s probe revealed that substantial funds credited to contractors’ accounts—originating from RG Kar Medical College and Hospital—were systematically diverted and siphoned off. This was done through:

  • Withdrawals using bearer cheques issued to close associates

  • Transfers to associate firms, followed by cash withdrawals

  • Routing funds through multiple layers of financial transactions

These actions were allegedly undertaken to conceal, disguise, and project the Proceeds of Crime as untainted money

Illegal Gratification and Disproportionate Assets

In exchange for extending illegal patronage and awarding contracts worth approximately ₹6.89 crore, Sandip Ghosh allegedly received illegal gratification and pecuniary benefits from the contractors.

The investigation also revealed that:

  • His income from private medical practice was meagre

  • Cash deposits in his bank accounts were grossly disproportionate to his known sources of income

  • Large cash receipts were falsely shown as professional medical fees, despite no medical services being rendered

  • These funds were allegedly deposited into the bank accounts of Sandip Ghosh and his wife, and later transferred to family members under the guise of gifts, knowingly projecting tainted money as legitimate.

    Searches and Attachment of Properties

    Earlier, search operations were conducted under Section 17 of the PMLA, 2002, leading to the seizure of incriminating documents and records. The ED has also identified and provisionally attached movable and immovable properties worth ₹52,38,651 belonging to Sandip Ghosh. 

  • Current Status

    The Prosecution Complaint has now been filed, and further investigation is still in progress. The case highlights serious concerns regarding corruption, misuse of public office, and laundering of public funds within the healthcare system.

DGFT Amends Import Policy for Umbrellas under ITC (HS) 2022

Import Policy Update: Platinum Articles Now Restricted (ITC HS 71141920)

The Directorate General of Foreign Trade (DGFT) has issued Notification No. 58/2025-26 dated 5 February 2026, bringing an important change in the import policy for Articles of Platinum under ITC (HS) Code 71141920, covered in Chapter 71 of ITC (HS), 2022.

???? What Has Changed?

Earlier, the import of Articles of Platinum was classified as “Free”. With immediate effect, this category has now been moved to “Restricted”.

This means that importers can no longer freely import platinum articles and will need to comply with specific policy conditions and approvals as prescribed under the Foreign Trade Policy.

???? New Policy Condition Introduced

DGFT has introduced Policy Condition No. 6 in Chapter 71, which clearly states:

Import of Platinum Articles is Restricted

However, relief has been provided for certain genuine cases where re-import will still be allowed under the Free category.

✅ Re-imports Allowed Without Restriction

The following categories of re-import of Indian origin platinum articles will continue to remain Free:

  1. Goods sent abroad for exhibitions or export promotion tours and brought back to India.

  2. Goods rejected, returned, or remaining unsold by overseas buyers.

  3. Goods sent abroad for repair and re-imported after repair.

???? Practical Impact

  • Jewellery manufacturers, traders, and importers dealing in platinum articles must re-evaluate their import plans.

  • New imports will require specific authorization under the restricted category.

  • Proper documentation will be critical to prove Indian origin in case of re-imports.

???? Why This Matters

Platinum is a high-value precious metal, and this move signals tighter regulatory control to monitor imports, prevent misuse, and ensure better compliance with foreign trade norms.

If you are involved in the jewellery, precious metals, or import-export business, this update is crucial for avoiding delays, penalties, or non-clearance of goods.